Reneuron Share Discussion Threads

[dmhzx] 28/3/2018 22:35

And to think of all the money they wasted on share consolidation. Soon be back to a few pence again

[waterloo01] 26/3/2018 16:56

Nothing much happening in 2018 and not much reason to invest IMO.

[dickbush] 26/3/2018 16:31

News of a more expensive tomorrow.

[waterloo01] 20/3/2018 12:26

No it isn't as this and many of the next wave of studies use patients own stem cells, which is an increasing trend and one reason this is under £1.00

[stewart_25] 20/3/2018 12:23

great news - but is rene directly involved with this particular news article - no reference if so...

[dickbush] 16/3/2018 16:38

It seems there are only sellers no matter how far down the bid goes.

[yachtmaster2] 16/3/2018 14:37

Well sold out today to mitigate my capital gains tax bill. At least it’s been of some use! Probably rocket now!

[konkel] 28/2/2018 09:13

Market Cap. £30m...cash (end Sept. 2017) £45m!!

[dickbush] 22/2/2018 11:43

cratesso

Thanks for that article. It looks as though RENE missed a major opportunity. They have stem cells and exosomes but went for improving the mobility of stroke victims many months after a stroke, results from which have been less than exciting.

Still, while bad news for RENE, this looks like potentially very good news for stroke victims.

[crt131] 22/2/2018 08:15

Broker targets starting to look realistic now!

[ps0u3165] 21/2/2018 19:37

10 yrs ago this was trading at 40p and it was suggest them that HRH had bought in at £1 must have been when they first listed.

[nsk1] 21/2/2018 19:23

I can't understand the BOD's logic in consolidating, most likely reason it's to keep the gravy train rolling & BOD wages rolling in. I agree with below comment, I to was a mug on this one.

[yachtmaster2] 21/2/2018 18:40

Woodford must be feeling like a bit of a twit as well!

[yachtmaster2] 21/2/2018 18:38

Dreadful!!!what a mug I’ve been with this!

[bigspuds] 21/2/2018 18:17

Looks like 1p on the cards. Then again.......

[cratesso] 21/2/2018 18:04

Reverse splits just upset holders and create more headroom for shorters. Science looks good though :)

[volsung] 21/2/2018 17:34

Abandon hope all ye who enter here!!

[dennisbergkamp] 21/2/2018 17:13

Totally agree, so surprising too.

D

[nsk1] 21/2/2018 16:43

What a disaster this has turned into

[cratesso] 21/2/2018 09:20

hxxps://newatlas.com/stroke-stem-cell-treatment/53478

Researchers at the University of Georgia have developed a new stem-cell-based treatment for strokes. When tested in animal models, the technique was found to reduce brain damage and help the brain heal itself faster, and the results have been promising enough that human clinical trials may follow as soon as next year.

According to the CDC, strokes affect almost 800,000 people every year in the US, and of those about 140,000 die as a result – making it the fifth-leading cause of death in the country. Survivors usually face a long period of rehabilitation, and in severe cases permanent brain damage can follow. Previous research into possible stroke treatments has included existing anti-inflammatory drugs, peptides found in spider venom, and a custom-made catheter for removing clots.

A particularly promising line of treatment involves stem cells. A few years ago, a London study used a certain set of CD34+ stem cells to trigger the growth of new brain tissue and blood vessels. Later, a Stanford study managed to restore mobility in the limbs of stroke victims after injecting stem cells into the brain.

The new study, conducted by researchers from the University of Georgia's Regenerative Bioscience Center and spinout startup ArunA Biomedical, also uses stem cells. Dubbed AB126, the treatment uses exosomes, tiny tube-shaped structures generated by neural stem cells. Since these structures are smaller than cells, they're able to cross certain barriers that cells can't, carrying and delivering multiple doses of regenerative therapeutics to where they're most needed.

"This is truly exciting evidence, because exosomes provide a stealth-like characteristic, invisible even to the body's own defenses," says Steven Stice, lead researcher on the study. "When packaged with therapeutics, these treatments can actually change cell progression and improve functional recovery."

The researchers tested AB126 on mice, and found that the treatment improved the recovery of motor control and memory in stroke victims. Next, the team compared MRI scans of mice who had been treated with AB126 to stroke-affected animals that hadn't received the treatment. They found that the treatment shrunk the size of the injury by about 35 percent, and halved the amount of brain tissue that was lost as a result of stroke.

"Until now, we had very little evidence specific to neural exosome treatment and the ability to improve motor function," says Stice. "Just days after stroke, we saw better mobility, improved balance and measurable behavioral benefits in treated animal models."

The researchers followed up the study with a test in pigs, and found similar results. Encouraged by that, the team is now preparing for human studies, which are set to kick off in 2019.

The research was published in the journal Translational Stroke Research.

Source: University of Georgia

[dickbush] 14/2/2018 14:07

Looks good to me.

[small crow] 13/2/2018 10:59

Interesting RNS."The development of a targeted, stem-cell based repair product, available to all surgeons, especially in the emergency setting, would represent a massive breakthrough in care.""

[dickbush] 09/2/2018 16:17

Another one bites the dust...

[sunwukong] 07/2/2018 22:49

"Do the charts tell anything?" - All charts tell you is what has gone, not what is coming. Makes no difference in predicting price movements. Charts cannot tell you why, what, or when buyers are going to buy, and why, what or when sellers are going to sell. There is a whole world of movements in the global economy for which you have to bring your own judgement - what else is there?